|
US3993754A
(en)
|
1974-10-09 |
1976-11-23 |
The United States Of America As Represented By The United States Energy Research And Development Administration |
Liposome-encapsulated actinomycin for cancer chemotherapy
|
|
GB1521000A
(en)
|
1975-06-13 |
1978-08-09 |
Syntex Puerto Rico Inc |
Inhalation device
|
|
US4086257A
(en)
|
1976-10-12 |
1978-04-25 |
Sears Barry D |
Phosphatidyl quaternary ammonium compounds
|
|
CH624011A5
(https=)
|
1977-08-05 |
1981-07-15 |
Battelle Memorial Institute |
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4529561A
(en)
|
1978-03-24 |
1985-07-16 |
The Regents Of The University Of California |
Method for producing liposomes in selected size range
|
|
US4227522A
(en)
|
1978-09-05 |
1980-10-14 |
Syntex Puerto Rico, Inc. |
Inhalation device
|
|
US4192309A
(en)
|
1978-09-05 |
1980-03-11 |
Syntex Puerto Rico, Inc. |
Inhalation device with capsule opener
|
|
US4451447A
(en)
|
1980-03-31 |
1984-05-29 |
Bristol-Myers Company |
Pharmaceutical formulations
|
|
US4522803A
(en)
|
1983-02-04 |
1985-06-11 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles, their preparation and use
|
|
US5435989A
(en)
|
1982-03-30 |
1995-07-25 |
Vestar, Inc. |
Method of targeting a specific location in a body
|
|
US4778054A
(en)
|
1982-10-08 |
1988-10-18 |
Glaxo Group Limited |
Pack for administering medicaments to patients
|
|
DK172541B1
(da)
|
1982-10-08 |
1998-12-07 |
Glaxo Group Ltd |
Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
|
|
US4981692A
(en)
|
1983-03-24 |
1991-01-01 |
The Liposome Company, Inc. |
Therapeutic treatment by intramammary infusion
|
|
US5030453A
(en)
|
1983-03-24 |
1991-07-09 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
|
US4588578A
(en)
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
|
US5169637A
(en)
|
1983-03-24 |
1992-12-08 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles
|
|
USRE33071E
(en)
|
1983-03-28 |
1989-09-26 |
|
Platinum bound to transferrin for use in the treatment of breast tumors
|
|
US4590001A
(en)
|
1983-03-28 |
1986-05-20 |
Stjernholm Rune L |
Platinum bound to transferrin for use in the treatment of breast tumors
|
|
US4572425A
(en)
|
1983-08-01 |
1986-02-25 |
Russell William S |
Reusable container
|
|
EP0153955A1
(en)
|
1983-09-06 |
1985-09-11 |
Health Research, Inc. |
Liposome delivery method for decreasing the toxicity of an antitumor drug
|
|
US4721612A
(en)
|
1984-04-12 |
1988-01-26 |
The Liposome Company, Inc. |
Steroidal liposomes
|
|
US5008050A
(en)
|
1984-06-20 |
1991-04-16 |
The Liposome Company, Inc. |
Extrusion technique for producing unilamellar vesicles
|
|
US5077056A
(en)
|
1984-08-08 |
1991-12-31 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
CA1270198A
(en)
|
1984-08-08 |
1990-06-12 |
Marcel B. Bally |
Encapsulation of antineoplastic agents in liposomes
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4975282A
(en)
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
|
US5059421A
(en)
|
1985-07-26 |
1991-10-22 |
The Liposome Company, Inc. |
Preparation of targeted liposome systems of a defined size distribution
|
|
DE3682457D1
(de)
|
1985-07-30 |
1991-12-19 |
Glaxo Group Ltd |
Geraet zur verabreichung von medikamenten an patienten.
|
|
JPH0665648B2
(ja)
|
1985-09-25 |
1994-08-24 |
塩野義製薬株式会社 |
白金系抗癌物質の安定な凍結真空乾燥製剤
|
|
US4861580A
(en)
|
1985-10-15 |
1989-08-29 |
The Liposome Company, Inc. |
Composition using salt form of organic acid derivative of alpha-tocopheral
|
|
US5041581A
(en)
|
1985-10-18 |
1991-08-20 |
The University Of Texas System Board Of Regents |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5117022A
(en)
|
1985-10-18 |
1992-05-26 |
The Board Of Regents, The University Of Texas System |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5049388A
(en)
|
1986-11-06 |
1991-09-17 |
Research Development Foundation |
Small particle aerosol liposome and liposome-drug combinations for medical use
|
|
US5320906A
(en)
|
1986-12-15 |
1994-06-14 |
Vestar, Inc. |
Delivery vehicles with amphiphile-associated active ingredient
|
|
CA1338702C
(en)
|
1987-03-05 |
1996-11-12 |
Lawrence D. Mayer |
High drug:lipid formulations of liposomal- antineoplastic agents
|
|
US5616334A
(en)
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
|
MX9203808A
(es)
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
|
DE3852037T2
(de)
|
1987-07-29 |
1995-03-23 |
Liposome Co Inc |
Verfahren zur trennung von teilchen nach grösse.
|
|
IL83380A
(en)
|
1987-07-30 |
1991-04-15 |
Teva Pharma |
Stable aqueous cisplatin solutions
|
|
DE68901733T2
(de)
|
1988-03-04 |
1993-03-25 |
Takeda Chemical Industries Ltd |
Liposom-zusammensetzung.
|
|
US5141751A
(en)
|
1988-06-29 |
1992-08-25 |
Daiichi Pharmaceutical Co., Ltd. |
Lipid membrane structures
|
|
US5077057A
(en)
|
1989-04-05 |
1991-12-31 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5225212A
(en)
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
JPH05963A
(ja)
|
1990-04-13 |
1993-01-08 |
Toray Ind Inc |
ポリペプチド類組成物
|
|
US5747469A
(en)
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
|
JP3220180B2
(ja)
|
1991-05-23 |
2001-10-22 |
三菱化学株式会社 |
薬剤含有タンパク質結合リポソーム
|
|
US5858784A
(en)
|
1991-12-17 |
1999-01-12 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol- and liposome-based delivery
|
|
US5756353A
(en)
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
|
EP0551169A1
(en)
|
1992-01-10 |
1993-07-14 |
Takeda Chemical Industries, Ltd. |
Liposome composition and production thereof
|
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
|
US5958449A
(en)
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
|
CN1088777A
(zh)
|
1992-12-18 |
1994-07-06 |
丛繁滋 |
用于癌病灶直接给药的化疗药物制剂的制备方法
|
|
US5665383A
(en)
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of immunostimulating agents for in vivo delivery
|
|
US5780054A
(en)
|
1996-01-17 |
1998-07-14 |
University Of British Columbia |
Methods for increasing the circulation half-life of protein-based therapeutics
|
|
AU2230497A
(en)
|
1996-02-26 |
1997-09-10 |
Daiichi Pharmaceutical Co., Ltd. |
Liposome and liposome dispersion
|
|
ES2201296T3
(es)
|
1996-04-26 |
2004-03-16 |
Genaera Corporation |
Escualmina en combinacion con otros farmacos anticancerigenos para el tratamiento de tumores.
|
|
CA2263455C
(en)
|
1996-08-23 |
2002-10-29 |
Sequus Pharmaceuticals, Inc. |
Liposomes containing a cisplatin compound
|
|
US5997899A
(en)
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
|
AU7711096A
(en)
|
1996-12-03 |
1998-06-29 |
Rijsuniversiteit Utrecht |
Cisplatinum comprising pharmaceutical
|
|
US6451784B1
(en)
|
1996-12-30 |
2002-09-17 |
Battellepharma, Inc. |
Formulation and method for treating neoplasms by inhalation
|
|
EP0954283B1
(en)
|
1996-12-30 |
2007-03-21 |
Battelle Memorial Institute |
Use of a non-encapsulated anticancer drug for the preparation of a formulation for treating neoplasms by inhalation
|
|
WO1998033481A1
(en)
|
1997-02-05 |
1998-08-06 |
Pharmacia & Upjohn Company |
Lipid complexes and liposomes of highly insoluble platinum complexes
|
|
FR2759293B1
(fr)
|
1997-02-11 |
1999-04-30 |
Ethypharm Lab Prod Ethiques |
Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
|
|
US6630168B1
(en)
|
1997-02-20 |
2003-10-07 |
Biomedicines, Inc. |
Gel delivery vehicles for anticellular proliferative agents
|
|
US6090407A
(en)
|
1997-09-23 |
2000-07-18 |
Research Development Foundation |
Small particle liposome aerosols for delivery of anti-cancer drugs
|
|
US7348025B2
(en)
|
1997-09-23 |
2008-03-25 |
Research Development Foundation |
Small particle liposome aerosols for delivery of anticancer drugs
|
|
US6787132B1
(en)
|
1997-12-04 |
2004-09-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Combined chemo-immunotherapy with liposomal drugs and cytokines
|
|
US6726925B1
(en)
|
1998-06-18 |
2004-04-27 |
Duke University |
Temperature-sensitive liposomal formulation
|
|
CA2248592A1
(en)
|
1998-08-31 |
2000-02-29 |
Christopher D. Batich |
Microspheres for use in the treatment of cancer
|
|
ES2156506B1
(es)
|
1998-10-14 |
2002-03-01 |
Sumitomo Chemical Co |
Metodo para la produccion de oxido de propileno.
|
|
DE69935154T2
(de)
|
1998-11-12 |
2007-10-25 |
Inc. Transave |
Inhalationssystem
|
|
US20050074499A1
(en)
|
1999-03-17 |
2005-04-07 |
Mitsubishi Chemical Corporation |
Ligand-bonded complex
|
|
US7244448B2
(en)
|
2000-06-30 |
2007-07-17 |
Tekmira Pharmaceuticals Corporation |
Liposomal antineoplastic drugs and uses thereof
|
|
US6723338B1
(en)
|
1999-04-01 |
2004-04-20 |
Inex Pharmaceuticals Corporation |
Compositions and methods for treating lymphoma
|
|
US6852334B1
(en)
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
JP2003503313A
(ja)
|
1999-06-03 |
2003-01-28 |
ジェシー エル エス オウ |
細胞増殖及び細胞死を変調する方法及び組成物
|
|
US6352996B1
(en)
|
1999-08-03 |
2002-03-05 |
The Stehlin Foundation For Cancer Research |
Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
|
|
US6800437B1
(en)
|
1999-08-06 |
2004-10-05 |
Tibotec Bvba |
Method of monitoring a biological system by labeling with an apo metal binding protein
|
|
WO2001032139A2
(en)
|
1999-11-05 |
2001-05-10 |
Seed Capital Investment-2 (Sci-2) B.V. |
Method for the formulation of substances having a low water-solubility and lipophilicity and formulation thus obtained
|
|
US6511676B1
(en)
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
KR100799089B1
(ko)
|
1999-12-04 |
2008-01-29 |
리서치 디벨럽먼트 파운데이션 |
에어로졸화된 약물의 침착 증진 조성물
|
|
JP4786105B2
(ja)
|
2000-02-04 |
2011-10-05 |
リポクセン テクノロジーズ リミテッド |
リポソーム
|
|
JP2003528131A
(ja)
|
2000-03-29 |
2003-09-24 |
アラダイム コーポレーション |
カチオン性リポソーム
|
|
AU2001260270A1
(en)
|
2000-05-02 |
2001-11-12 |
Pharmacept Gmbh |
Liposomes containing active substances
|
|
US6998393B2
(en)
|
2000-06-23 |
2006-02-14 |
Biopharm Solutions, Inc. |
Aquespheres, their preparation and uses thereof
|
|
US6989156B2
(en)
|
2001-04-23 |
2006-01-24 |
Nucryst Pharmaceuticals Corp. |
Therapeutic treatments using the direct application of antimicrobial metal compositions
|
|
WO2002060412A2
(en)
|
2001-02-01 |
2002-08-08 |
Board Of Regents |
Stabilised polymeric aerosols for pulmonary gene delivery
|
|
PT1320355E
(pt)
|
2001-05-18 |
2006-08-31 |
Chiron Corp |
Sistema para administracao de uma formulacao de tobramicina
|
|
US7063860B2
(en)
|
2001-08-13 |
2006-06-20 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
|
JP2005502653A
(ja)
|
2001-08-20 |
2005-01-27 |
トランセーヴ・インコーポレーテッド |
肺ガンの治療方法
|
|
CA2457148A1
(en)
|
2001-08-20 |
2003-02-27 |
Transave, Inc. |
Treatment of cancers by inhalation of stable platinum-containing formulations
|
|
WO2003075889A1
(en)
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
An inhalation system for prevention and treatment of intracellular infections
|
|
JP3415131B1
(ja)
|
2002-06-03 |
2003-06-09 |
メビオファーム株式会社 |
リポソーム製剤
|
|
US20040022842A1
(en)
|
2002-06-03 |
2004-02-05 |
Mebiopharm Co., Ltd. |
Liposome preparations containing oxaliplatin
|
|
US9186322B2
(en)
|
2002-08-02 |
2015-11-17 |
Insmed Incorporated |
Platinum aggregates and process for producing the same
|
|
JP2006502233A
(ja)
|
2002-08-02 |
2006-01-19 |
トランセーブ，インク． |
白金凝集物およびその製造方法
|
|
EP1581236B1
(en)
|
2002-10-29 |
2013-10-16 |
Insmed Incorporated |
Sustained release of antiinfectives
|
|
JP4874547B2
(ja)
|
2002-11-26 |
2012-02-15 |
ギリアード サイエンシーズ， インコーポレイテッド |
勾配によるリポソームへの薬物充填方法
|
|
NZ548195A
(en)
|
2004-01-14 |
2011-01-28 |
Gilead Sciences Inc |
Lipid-based dispersions useful for drug delivery
|
|
US20070065522A1
(en)
*
|
2004-03-18 |
2007-03-22 |
Transave, Inc. |
Administration of high potency platinum compound formulations by inhalation
|
|
WO2005089448A2
(en)
|
2004-03-18 |
2005-09-29 |
Transave, Inc. |
Administration of cisplatin by inhalation
|
|
US8221739B2
(en)
*
|
2004-04-29 |
2012-07-17 |
Botanic Oil Innovations, Inc. |
Method of cancer treatment
|
|
CN101001633A
(zh)
|
2004-05-21 |
2007-07-18 |
特兰萨夫公司 |
肺病和肺病前期病症的治疗
|
|
US20060246124A1
(en)
|
2004-11-08 |
2006-11-02 |
Pilkiewicz Frank G |
Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
|
|
EP1830813A2
(en)
|
2004-12-14 |
2007-09-12 |
Transave, Inc. |
Lipid particles comprising bioactive agents, methods of preparing and uses thereof
|
|
WO2006113181A2
(en)
*
|
2005-04-08 |
2006-10-26 |
University Of Florida Research Foundation, Inc. |
Stem-like cells in bone sarcomas
|
|
US20090130194A1
(en)
*
|
2005-11-08 |
2009-05-21 |
Transave, Inc. |
Methods of Treating Cancer with High Potency Lipid-Based Platinum Compound Formulations Administered Intravenously
|
|
WO2007056264A2
(en)
|
2005-11-08 |
2007-05-18 |
Transave, Inc. |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
|
US20070122350A1
(en)
|
2005-11-30 |
2007-05-31 |
Transave, Inc. |
Safe and effective methods of administering therapeutic agents
|
|
GR20060100144A
(el)
|
2006-03-03 |
2007-10-17 |
|
Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene
|
|
US8252302B2
(en)
|
2007-06-11 |
2012-08-28 |
Edge Therapeutics, Inc. |
Methods and compositions to treat hemorrhagic conditions of the brain
|
|
SG176064A1
(en)
*
|
2009-05-14 |
2011-12-29 |
Oatmeal Biotechnologies Group L L C |
Platform technologies for spontaneously occurring diseases
|
|
WO2012009703A2
(en)
*
|
2010-07-16 |
2012-01-19 |
Epeius Biotechnologies Corporation |
Targeted nanoparticles for cancer and other disorders
|
|
CN121606602A
(zh)
|
2012-09-04 |
2026-03-06 |
埃莱森制药股份有限公司 |
用顺铂脂质复合物预防癌症的肺部复发
|